IFNG and neoplasm: In addition, IFNγ secreted by CD8+ T cells, which are activated by immunotherapy binds to IFNR, activates the JAK-STAT1-IRF1 signaling axis, and induces the expression of ACSL4 in tumor cells (Liao et al., 2022).